ATE420109T1 - Konstitutiv translozierende zelllinie - Google Patents

Konstitutiv translozierende zelllinie

Info

Publication number
ATE420109T1
ATE420109T1 AT03726733T AT03726733T ATE420109T1 AT E420109 T1 ATE420109 T1 AT E420109T1 AT 03726733 T AT03726733 T AT 03726733T AT 03726733 T AT03726733 T AT 03726733T AT E420109 T1 ATE420109 T1 AT E420109T1
Authority
AT
Austria
Prior art keywords
agonist
present
methods
translocing
constitutive
Prior art date
Application number
AT03726733T
Other languages
English (en)
Inventor
Robert Oakley
Christine Hudson
Original Assignee
Molecular Devices Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Devices Corp filed Critical Molecular Devices Corp
Application granted granted Critical
Publication of ATE420109T1 publication Critical patent/ATE420109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03726733T 2002-05-13 2003-05-12 Konstitutiv translozierende zelllinie ATE420109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37998602P 2002-05-13 2002-05-13
US40169802P 2002-08-07 2002-08-07

Publications (1)

Publication Number Publication Date
ATE420109T1 true ATE420109T1 (de) 2009-01-15

Family

ID=29553491

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726733T ATE420109T1 (de) 2002-05-13 2003-05-12 Konstitutiv translozierende zelllinie

Country Status (8)

Country Link
US (3) US7332292B2 (de)
EP (1) EP1504030B1 (de)
JP (1) JP2005525814A (de)
AT (1) ATE420109T1 (de)
AU (1) AU2003228956B2 (de)
CA (1) CA2483692A1 (de)
DE (1) DE60325719D1 (de)
WO (1) WO2003097795A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420109T1 (de) * 2002-05-13 2009-01-15 Molecular Devices Corp Konstitutiv translozierende zelllinie
WO2004014296A2 (en) * 2002-08-13 2004-02-19 U.S. Department Of Veterans Affairs Method of detecting and preventing alzheimer’s disease, particularly at prodromal and early stages
WO2004034054A2 (en) * 2002-10-11 2004-04-22 7Tm Pharma A/S Method for enhancing and prolonging the bioluminescence resonance energy transfer (bret) signal in a bret assay and a substrate solution for use in a bret assay
DE60325640D1 (de) 2002-10-25 2009-02-12 Mds Analytical Technologies Us Verfahren zur identifizierung von transmembranrezeptoragonisten mit reduzierter internalisierung
WO2005047905A1 (en) * 2003-10-28 2005-05-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 22 (gpr22)
ES2353604T3 (es) * 2004-04-20 2011-03-03 Galapagos N.V. Métodos, composiciones y ensayos de compuestos para inhibir la producción de proteína beta-amiloide.
US20070135499A1 (en) * 2005-07-11 2007-06-14 Aerie Pharmaceuticals, Inc. Hydrazide compounds
EP1910297B1 (de) * 2005-07-11 2016-05-25 Aerie Pharmaceuticals, Inc. Isochinolinverbindungen
US7763437B1 (en) * 2005-07-15 2010-07-27 Duke University Methods for identifying compounds that regulate β-Arrestin signaling complexes
WO2007065101A1 (en) * 2005-11-30 2007-06-07 Axitare, Inc. Compositions and methods of modulating the taste and smell receptors and screening methods therefore
WO2008036540A2 (en) 2006-09-20 2008-03-27 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US8455513B2 (en) * 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
JP2012525386A (ja) 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
CA2853722A1 (en) 2011-10-27 2013-05-02 Mayo Foundation For Medical Education And Research Inhibiting g protein coupled receptor 6 kinase polypeptides
ITMI20112038A1 (it) * 2011-11-10 2013-05-11 Arterra Bioscience S R L "nuovi recettori gpcr chimerici, loro usi per lo screening di fitofarmaci, e metodi di screening relativi"
JP2016515520A (ja) 2013-03-15 2016-05-30 アエリエ・ファーマシューティカルズ・インコーポレーテッド 併用療法
WO2015164411A2 (en) 2014-04-21 2015-10-29 Mayo Foundation For Medical Education And Research Small molecule inhibitors of g protein coupled receptor 6 kinases polypeptides
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
JP6832946B2 (ja) 2015-11-17 2021-02-24 アエリエ ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤およびその中間体の調製方法
CN109640966A (zh) 2016-08-31 2019-04-16 爱瑞制药公司 眼用组合物
BR112019020078A2 (pt) 2017-03-31 2020-04-28 Aerie Pharmaceuticals Inc compostos e composições farmacêuticas à base de arilciclopropil-amino-isoquinolinil amida e métodos de uso dos mesmos
EP3849555A4 (de) 2018-09-14 2022-05-04 Aerie Pharmaceuticals, Inc. Aryl-cyclopropyl-amino-isochinolinyl-amidverbindungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427912A (en) * 1993-08-27 1995-06-27 Boehringer Mannheim Corporation Electrochemical enzymatic complementation immunoassay
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5777079A (en) 1994-11-10 1998-07-07 The Regents Of The University Of California Modified green fluorescent proteins
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US6893827B1 (en) * 2000-02-07 2005-05-17 Applera Corporation Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
US7279324B2 (en) * 2001-01-23 2007-10-09 Duke University Nucleic acid encoding G-protein coupled receptor with modified DRY motif
US20030013137A1 (en) 2001-03-13 2003-01-16 Barak Larry S. Automated methods of detecting receptor activity
US20030182669A1 (en) 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
ATE420109T1 (de) * 2002-05-13 2009-01-15 Molecular Devices Corp Konstitutiv translozierende zelllinie

Also Published As

Publication number Publication date
CA2483692A1 (en) 2003-11-27
EP1504030A2 (de) 2005-02-09
US20060029983A1 (en) 2006-02-09
AU2003228956B2 (en) 2009-10-01
EP1504030B1 (de) 2009-01-07
US20090081652A1 (en) 2009-03-26
WO2003097795A2 (en) 2003-11-27
AU2003228956A1 (en) 2003-12-02
US7332292B2 (en) 2008-02-19
WO2003097795A3 (en) 2004-06-24
US20050032125A1 (en) 2005-02-10
DE60325719D1 (de) 2009-02-26
EP1504030A4 (de) 2006-10-25
JP2005525814A (ja) 2005-09-02

Similar Documents

Publication Publication Date Title
ATE420109T1 (de) Konstitutiv translozierende zelllinie
Arshad et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
Zhou et al. Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors
Loland et al. Generation of an activating Zn2+ switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle
Blaskovic et al. What does S‐palmitoylation do to membrane proteins?
Urizar et al. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor
EP2901450B1 (de) Verfahren und vorrichtung zur codierung von tonsignalen
Zhu et al. Genetically encoding a light switch in an ionotropic glutamate receptor reveals subunit-specific interfaces
WO2000022131A3 (en) Non-endogenous, constitutively activated human g protein-coupled receptors
Takeda et al. Identification of surrogate ligands for orphan G protein-coupled receptors
AU2001234430A1 (en) Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
TW200604801A (en) Data mask as write-training feedback flag
WO2002059267A3 (en) Constitutively desensitized g protein-coupled receptors
CN102970638B (zh) 处理信号
Almqvist et al. Contributions of microstructure and crystallographic preferred orientation to seismic anisotropy in the lower continental crust
WO2004009770A3 (en) Methods and compositions for modulating agonist-induced downregulation of g protein-coupled receptors
Liu et al. The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells
JP2005309096A (ja) 音声復号化装置および音声復号化方法
Palla et al. Wearable speech enhancement system for motor impaired people
Itou et al. Evidence for the existence of cytochrome b558 in fish neutrophils by polyclonal anti-peptide antibody
Mahajan et al. Natural System Mimics: Development and Evaluation of Formation/Decomposition Methods for Methane Hydrate Hosted in Fine Sediments
Kawagoe Consonant Gemination in Loanword Phonology and Rhythm Clash
Hu et al. Determination of four trihalomethanes in ship ballast water by gas chromatography-negative chemical ionization-mass spectrometry
Westrick-Snapp et al. Investigating the Drumian Carbon Isotope Excursion (DICE) in the Cambrian Bonanza King Formation of the Western Great Basin.
Somers The Pitarrilla, silver-zinc-lead deposit, Sierra Madre Occidental: a reconstruction of its volcano-sedimentary environment, a description of its mineralization and alteration styles and petrogenesis of its Eocene and Oligocene volcanic strata.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties